AZN:NASDAQ, AstraZeneca PLC

AZN stock overview

AstraZeneca PLC (AZN:NASDAQ) closed at $172.57 on October 22, 2026, up 2.45% on the day. The stock trades 18.9% below its 52-week high of $212.71 and 12.5% above its 52-week low of $153.41. Over the past year, it gained 1.0%. AstraZeneca PLC is part of the Miscellaneous sector.

Key figures

Price: $172.57
Day change: +2.45%
Volume: 2,773,214
Average volume: 3,401,710
Market cap: 267B+
52-week range: $153.41 – $212.71
50-day average: $162.52
200-day average: $180.71

Price action over the past year

In 252 trading sessions since October 22, 2025, AZN closed higher on 125 days (50%). Its best day was July 2, 2026 (+6.14%) and its worst was August 3, 2026 (-6.88%). It never moved 10% or more in a single session.

Recent signals

Oct 22, 2026: News catalyst: Biotech (News Catalysts scanner)
Oct 21, 2026: Trading sideways between $155.62 and $173.30 over 90 days (Sideways scanner)

AZN news

Oct 22, 2026: SAP Stock Jumps After Earnings. How the Software Giant Became an AI Winner.
Oct 22, 2026: European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading
Oct 22, 2026: AstraZeneca Gets Accelerated FDA Nod for Ultomiris in IgA Nephropathy
Oct 22, 2026: AstraZeneca Launches Targeted Lung Cancer Drug In US After FDA Accelerated Approval
Oct 22, 2026: Summit Expands Ivonescimab Development Into Biliary Tract Cancer
Oct 22, 2026: AstraZeneca bags another US indication for Ultomiris with IgAN approval
Oct 22, 2026: P&G, Nestlé, Mars, AstraZeneca, ITC and Bekaert win OMP Supply Chain Awards
Oct 22, 2026: ZEGFROVY® (sunvozertinib) now available in the US for patients with previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations

About AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its revenue.

Similar stocks

Find more stocks like AZN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.